Evogene (EVGN) Short Interest Ratio & Short Volume $1.45 +0.10 (+7.41%) (As of 12:48 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Evogene Short Interest DataEvogene (EVGN) has a short interest of 82,000 shares, representing 1.55% of the float (the number of shares available for trading by the public). This marks a -39.30% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 87,066 shares to cover all short positions.Current Short Interest82,000 sharesPrevious Short Interest135,100 sharesChange Vs. Previous Month-39.30%Dollar Volume Sold Short$132,020.00Short Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares5,365,000 sharesFloat Size5,280,000 sharesShort Percent of Float1.55%Today's Trading Volume79,348 sharesAverage Trading Volume87,066 sharesToday's Volume Vs. Average91% Short Selling Evogene? Sign up to receive the latest short interest report for Evogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVGN Short Interest Over TimeEVGN Days to Cover Over TimeEVGN Percentage of Float Shorted Over Time Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Evogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202482,000 shares $132,020.00 -39.3%1.6%0.3 $1.61 11/15/2024135,100 shares $233,723.00 +503.1%2.6%0.5 $1.73 10/31/202422,400 shares $51,072.00 -16.4%0.5%0.1 $2.28 10/15/202426,800 shares $66,732.00 +83.6%0.5%0.8 $2.49 9/30/202414,600 shares $44,822.00 -39.7%0.3%0.5 $3.07 9/15/202424,200 shares $69,696.00 -0.8%0.5%1 $2.88 Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 8/31/202424,400 shares $80,276.00 +5.6%0.5%1.1 $3.29 8/15/202423,100 shares $96,096.00 -22.7%0.5%1.1 $4.16 7/31/202429,900 shares $145,015.00 +864.5%0.6%1.8 $4.85 7/15/20243,100 shares $19,747.00 -95.0%N/A0 $6.37 6/30/202462,400 shares $40,584.96 +16.4%N/A0.8 $0.65 6/15/202453,600 shares $35,349.15 +8.5%N/A0.7 $0.66 5/31/202449,400 shares $36,803.00 -20.8%N/A0.6 $0.75 5/15/202462,400 shares $42,719.04 -36.2%N/A0.6 $0.68 4/30/202497,800 shares $67,755.84 +40.3%N/A0.6 $0.69 4/15/202469,700 shares $47,835.11 -19.4%N/A0.4 $0.69 3/31/202486,500 shares $64,875.00 +20.8%N/A0.5 $0.75 3/15/202471,600 shares $58,712.00 -47.5%N/A0.4 $0.82 2/29/2024136,300 shares $124,196.56 +25.7%N/A0.6 $0.91 2/15/2024108,400 shares $81,137.40 -11.0%N/A0.5 $0.75 1/31/2024121,800 shares $93,177.00 -3.0%N/A0.8 $0.77 1/15/2024125,500 shares $117,719.00 -18.4%N/A0.8 $0.94 12/31/2023153,700 shares $129,108.00 -17.9%N/A1 $0.84 12/15/2023187,200 shares $131,189.76 -35.0%N/A1.3 $0.70 11/30/2023287,800 shares $187,127.56 +32.3%N/A2.3 $0.65 11/15/2023217,500 shares $143,898.00 +20.6%N/A2 $0.66 10/31/2023180,400 shares $86,429.64 -28.8%N/A1.3 $0.48 10/15/2023253,400 shares $118,616.54 -11.3%N/A1.6 $0.47 9/30/2023285,600 shares $167,504.40 +20.0%N/A1 $0.59 9/15/2023238,000 shares $159,698.00 -8.9%N/A0.7 $0.67 8/31/2023261,100 shares $194,075.63 -12.7%N/A0.7 $0.74 8/15/2023299,200 shares $238,163.20 -10.7%N/A0.8 $0.80 7/31/2023334,900 shares $354,994.00 -33.8%N/A1 $1.06 7/15/2023505,800 shares $708,120.00 -8.5%N/A1.7 $1.40 6/30/2023552,800 shares $591,496.00 +118.7%1.4%3.5 $1.07 6/15/2023252,800 shares $195,161.60 +13.0%0.6%2 $0.77 5/31/2023223,800 shares $134,324.76 -22.5%0.6%3.1 $0.60 5/15/2023288,700 shares $193,313.52 +13.4%0.7%3.9 $0.67 4/30/2023254,500 shares $149,111.55 -1.3%0.6%3.1 $0.59 4/15/2023257,900 shares $149,917.27 +2.6%0.7%2.8 $0.58Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. 3/31/2023251,300 shares $158,319.00 +42.9%0.6%2.6 $0.63 3/15/2023175,900 shares $115,918.10 +11.2%0.4%1.6 $0.66 2/28/2023158,200 shares $120,232.00 -31.2%0.4%1.5 $0.76 2/15/2023230,000 shares $195,500.00 -7.9%0.6%2.1 $0.85 1/31/2023249,600 shares $199,655.04 +45.0%0.6%2.4 $0.80 1/15/2023172,200 shares $129,150.00 -0.9%0.4%1.9 $0.75 12/30/2022173,800 shares $121,660.00 -35.2%0.4%2 $0.70 12/15/2022268,100 shares $189,653.94 +42.6%0.7%2.9 $0.71 11/30/2022188,000 shares $117,970.00 -5.8%0.5%2.5 $0.63 11/15/2022199,600 shares $143,712.00 -19.4%0.5%2.5 $0.72 10/31/2022247,500 shares $180,675.00 +23.9%0.6%2.6 $0.73 10/15/2022199,700 shares $141,767.03 +3.2%0.5%1.9 $0.71 9/30/2022193,500 shares $160,605.00 -9.8%0.5%1.8 $0.83 9/15/2022214,400 shares $218,688.00 -1.1%0.6%1.9 $1.02 8/31/2022216,700 shares $225,368.00 +22.9%0.6%1.8 $1.04 8/15/2022176,300 shares $205,883.14 -22.7%0.5%1.4 $1.17 7/31/2022228,100 shares $187,042.00 -14.2%0.6%1.7 $0.82 7/15/2022265,700 shares $215,217.00 -21.4%0.7%1.9 $0.81 6/30/2022338,000 shares $260,260.00 -11.8%0.9%2.2 $0.77 6/15/2022383,300 shares $295,141.00 -29.4%1.0%2.3 $0.77 5/31/2022542,900 shares $514,397.75 -5.0%1.4%2.2 $0.95 5/15/2022571,400 shares $511,345.86 -24.8%1.5%2 $0.89 4/30/2022759,800 shares $805,388.00 +4.7%2.0%2.4 $1.06 4/15/2022725,900 shares $863,821.00 -5.4%1.9%2.2 $1.19 3/31/2022767,700 shares $998,010.00 -7.3%N/A2.2 $1.30 3/15/2022828,000 shares $968,760.00 +33.2%2.1%2.1 $1.17 2/28/2022621,700 shares $808,210.00 -9.5%1.6%1.9 $1.30 2/15/2022687,200 shares $872,744.00 -10.2%1.8%2.1 $1.27 1/31/2022765,000 shares $1.06 million +3.5%2.0%2.2 $1.39 1/15/2022739,000 shares $1.16 million +47.4%N/A2.2 $1.57 12/31/2021501,300 shares $822,132.00 -16.8%1.3%1.6 $1.64 12/15/2021602,500 shares $1.10 million +20.9%1.6%2 $1.82 11/30/2021498,400 shares $991,816.00 +5.3%1.3%1.7 $1.99 11/15/2021473,500 shares $1.16 million -14.1%1.2%1.3 $2.45 10/29/2021551,100 shares $1.44 million -33.2%1.5%1.7 $2.61 10/15/2021825,300 shares $2.21 million +9.9%2.2%2.4 $2.68 9/30/2021751,300 shares $1.98 million +1.2%2.0%2.2 $2.64 9/15/2021742,200 shares $2.03 million +26.3%2.0%2.1 $2.74 8/31/2021587,600 shares $1.76 million -22.5%1.5%1.6 $3.00 8/13/2021758,600 shares $2.26 million +17.1%2.0%2.1 $2.98 7/30/2021647,900 shares $1.85 million -6.8%1.7%1.7 $2.86 7/15/2021694,900 shares $2.14 million -11.6%1.8%1.7 $3.08 6/30/2021786,200 shares $2.69 million -4.0%2.1%1.7 $3.42 6/15/2021818,800 shares $2.97 million -16.6%2.2%1.5 $3.63 5/28/2021981,400 shares $3.42 million -16.8%2.6%1.6 $3.48 5/14/20211,180,000 shares $3.89 million +30.0%3.1%1.3 $3.30 4/30/2021908,000 shares $4.11 million -11.0%2.4%0.8 $4.53 4/15/20211,020,000 shares $4.72 million +18.3%N/A0 $4.63 3/31/2021862,000 shares $4.01 million +0.9%2.3%0.5 $4.65 3/15/2021854,100 shares $4.77 million -38.6%2.6%0.4 $5.59Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. 2/26/20211,390,000 shares $8.44 million +0.7%4.6%0.7 $6.07 2/12/20211,380,000 shares $13.72 million -16.9%4.6%0.7 $9.94 1/29/20211,660,000 shares $10.54 million +4.4%5.8%0.9 $6.35 1/15/20211,590,000 shares $9.46 million +62.2%5.3%1 $5.95 12/31/2020980,100 shares $4.80 million +68.6%3.6%0.7 $4.90 12/15/2020581,200 shares $2.30 million +56.3%2.1%0.5 $3.96 11/30/2020371,900 shares $1.10 million +17.8%1.4%0.3 $2.96 11/15/2020315,800 shares $802,132.00 +16.8%1.2%0.3 $2.54 10/30/2020270,400 shares $803,088.00 -27.9%1.2%0.3 $2.97 10/15/2020374,900 shares $1.42 million -47.0%1.6%0.4 $3.80 9/30/2020706,900 shares $2.80 million +1,022.1%3.8%0.9 $3.96 9/15/202063,000 shares $168,210.00 -37.5%0.3%0.1 $2.67 8/31/2020100,800 shares $208,656.00 +90.9%0.5%0.3 $2.07 8/14/202052,800 shares $73,920.00 -2.4%0.3%0.3 $1.40 7/31/202054,100 shares $56,285.64 -5.6%0.3%0.4 $1.04 7/15/202057,300 shares $55,581.00 +62.3%0.3%0.5 $0.97 6/30/202035,300 shares $35,289.41 -18.9%0.2%0.4 $1.00 6/15/202043,500 shares $45,240.00 -24.5%0.2%0.6 $1.04 5/29/202057,600 shares $60,480.00 +11.0%0.3%1.6 $1.05 5/15/202051,900 shares $52,938.00 -29.7%0.3%2.6 $1.02 4/30/202073,800 shares $82,929.06 +64.7%0.4%3.4 $1.12 4/15/202044,800 shares $47,040.00 +11.4%N/A2.2 $1.05 3/31/202040,200 shares $42,210.00 -61.6%N/A2 $1.05 3/13/2020104,800 shares $115,280.00 +147.8%N/A3.2 $1.10 2/28/202042,300 shares $38,493.00 +94.9%N/A2 $0.91 2/14/202021,700 shares $21,917.00 -32.6%0.1%1.2 $1.01 1/31/202032,200 shares $45,080.00 +7.7%0.2%2.2 $1.40 1/15/202029,900 shares $42,458.00 -26.7%0.1%3 $1.42 12/31/201940,800 shares $69,360.00 +229.0%0.2%4.6 $1.70 EVGN Short Interest - Frequently Asked Questions What is Evogene's current short interest? Short interest is the volume of Evogene shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 82,000 shares of EVGN short. 1.55% of Evogene's shares are currently sold short. Learn More on Evogene's current short interest. What is a good short interest percentage for Evogene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.55% of Evogene's floating shares are currently sold short. Is Evogene's short interest increasing or decreasing? Evogene saw a decline in short interest in November. As of November 30th, there was short interest totaling 82,000 shares, a decline of 39.3% from the previous total of 135,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evogene's float size? Evogene currently has issued a total of 5,365,000 shares. Some of Evogene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evogene currently has a public float of 5,280,000 shares. How does Evogene's short interest compare to its competitors? 1.55% of Evogene's shares are currently sold short. Here is how the short interest of companies in the industry of "chemicals" compare to Evogene: Gulf Resources, Inc. (0.48%), SenesTech, Inc. (4.76%), N2OFF, Inc. (1.09%), CN Energy Group. Inc. (0.05%), Tantech Holdings Ltd (9.22%), Linde plc (1.17%), Nutrien Ltd. (0.69%), Axalta Coating Systems Ltd. (1.97%), CSW Industrials, Inc. (2.12%), ICL Group Ltd (0.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Evogene stock? Short selling EVGN is an investing strategy that aims to generate trading profit from Evogene as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evogene? A short squeeze for Evogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVGN, which in turn drives the price of the stock up even further. How often is Evogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVGN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Gulf Resources Short Interest Data SenesTech Short Interest Data N2OFF Short Interest Data CN Energy Group. Short Interest Data Tantech Short Interest Data LanzaTech Global Short Interest Data Origin Materials Short Interest Data PureCycle Technologies Short Interest Data TLGY Acquisition Short Interest Data Linde Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVGN) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
